Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection

References

• Dachs GU, Dougherty GJ, Stratford IJ, Chaplin DJ. Targeting gene therapy to cancer: a review. Oncol Res 1997;9:313–25
   PubMed Web of Science ®Google Scholar
• Morille M, Passirani C, Vonarbourg A, et al. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008;29:3477–96
   PubMed Web of Science ®Google Scholar
• Bragonzi A, Dina G, Villa A, et al. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 2000;7:1753–60
   PubMed Web of Science ®Google Scholar
• Yeeprae W, Kawakami S, Suzuki S, et al. Physicochemical and pharmacokinetic characteristics of cationic liposomes. Pharmazie 2006;61:102–5
   PubMed Web of Science ®Google Scholar
• Hong K, Zheng W, Baker A, Papahadjopoulos D. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett 1997;400:233–7
   PubMed Web of Science ®Google Scholar
• Song YK, Liu D. Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration. Biochim Biophys Acta 1998;1372:141–50
   PubMed Web of Science ®Google Scholar
• Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993;261:209–11
   PubMed Web of Science ®Google Scholar
• Eliyahu H, Servel N, Domb AJ, Barenholz Y. Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery. Gene Ther 2002;9:850–8
   PubMed Web of Science ®Google Scholar
• Simberg D, Weisman S, Talmon Y, et al. The role of organ vascularization and lipoplex-serum initial contact in intravenous murine lipofection. J Biol Chem 2003;278:39858–65
   PubMed Web of Science ®Google Scholar
• Gjetting T, Arildsen NS, Christensen CL, et al. In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection. Int J Nanomedicine 2010;5:371–83
   PubMed Web of Science ®Google Scholar
• Ito T, Iida-Tanaka N, Koyama Y. Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid. J Drug Target 2008;16:276–81
   PubMed Web of Science ®Google Scholar
• Kurosaki T, Kitahara T, Fumoto S, et al. Chondroitin sulfate capsule system for efficient and secure gene delivery. J Pharm Pharm Sci 2010;13:351–61
   PubMed Web of Science ®Google Scholar
• Kurosaki T, Kitahara T, Kawakami S, et al. Gamma-polyglutamic acid-coated vectors for effective and safe gene therapy. J Control Release 2010;142:404–10
   PubMed Web of Science ®Google Scholar
• Bagari R, Bansal D, Gulbake A, et al. Chondroitin sulfate functionalized liposomes for solid tumor targeting. J Drug Target 2011;19:251–7
   PubMed Web of Science ®Google Scholar
• Song YK, Liu F, Chu S, Liu D. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther 1997;8:1585–94
   PubMed Web of Science ®Google Scholar
• Templeton NS, Lasic DD, Frederik PM, et al. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997;15:647–52
   PubMed Web of Science ®Google Scholar
• Lu C, Stewart DJ, Lee JJ, et al. Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One 2012;7:e34833
   PubMed Web of Science ®Google Scholar
• Kato M, Hattori Y, Kubo M, Maitani Y. Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex. Int J Pharm 2012;423:428–34
   PubMed Web of Science ®Google Scholar
• Igarashi S, Hattori Y, Maitani Y. Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome. J Control Release 2006;112:362–8
   PubMed Web of Science ®Google Scholar
• Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965;13:238–52
   PubMed Web of Science ®Google Scholar
• Hattori Y, Ding WX, Maitani Y. Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells. J Control Release 2007;120:122–30
   PubMed Web of Science ®Google Scholar
• Duarte S, Faneca H, Lima MC. Non-covalent association of folate to lipoplexes: a promising strategy to improve gene delivery in the presence of serum. J Control Release 2011;149:264–72
   PubMed Web of Science ®Google Scholar
• Hattori Y, Maitani Y. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther 2005;12:796–809
   PubMed Web of Science ®Google Scholar
• Loisel S, Floch V, Le GC, Ferec C. Factors influencing the efficiency of lipoplexes mediated gene transfer in lung after intravenous administration 1. J Liposome Res 2001;11:127–38
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bradshaw-Pierce EL, Delille A, et al. In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. J Pharm Sci 2008;97:237–50
   PubMed Web of Science ®Google Scholar
• Ghosh SC, Neslihan AS, Klostergaard J. CD44: a validated target for improved delivery of cancer therapeutics. Expert Opin Ther Targets 2012;16:635–50
   PubMed Web of Science ®Google Scholar
• Negi LM, Talegaonkar S, Jaggi M, et al. Role of CD44 in tumour progression and strategies for targeting. J Drug Target 2012;20:561–73
   PubMed Web of Science ®Google Scholar
• Loisel S, Le GC, Doucet L, et al. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther 2001;12:685–96
   PubMed Web of Science ®Google Scholar
• Mitsui M, Nishikawa M, Zang L, et al. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression. J Gene Med 2009;11:435–43
   PubMed Web of Science ®Google Scholar
• Auzenne E, Ghosh SC, Khodadadian M, et al. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia 2007;9:479–86
   PubMed Web of Science ®Google Scholar
• Zhang L, Yao J, Zhou J, Wang T, Zhang Q. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. Int J Pharm 2013;441:654--64
   Google Scholar
• Galic VL, Herzog TJ, Wright JD, Lewin SN. Paclitaxel poliglumex for ovarian cancer. Expert Opin Investig Drugs 2011;20:813–21
   PubMed Web of Science ®Google Scholar
• Ito T, Yoshihara C, Hamada K, Koyama Y. DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice. Biomaterials 2010;31:2912–8
   PubMed Web of Science ®Google Scholar
• Thurston G, McLean JW, Rizen M, et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest 1998;101:1401–3
   PubMed Web of Science ®Google Scholar
• Krasnici S, Werner A, Eichhorn ME, et al. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer 2003;105:561–7
   PubMed Web of Science ®Google Scholar